Bandhan Bank receives SEBI disclosure on acquisition of healthcare entities
Quadramedical Research and Foundation Pvt. Ltd., operating through subsidiary entities Quadra Hospital & Medical Services Pvt. Ltd. and Gamma Spect Imaging & Diagnostic Centre Pvt. Ltd., made formal disclosure under SEBI Takeover Regulations. The filing was submitted to NSE on 7 July 2026. The exact acquisition structure-whether direct stake purchase in Bandhan Bank or debt-to-equity conversion-and quantum of stake acquired or intended are not specified in the disclosure headline. This appears to be a preliminary or ongoing disclosure notification rather than a completed transaction announcement.
Why it mattersHealthcare entity acquisition of financial services stock triggers mandatory SEBI takeover disclosure regime; practitioner must review substantial acquisition provisions and open offer exemptions under Reg. 3, 4 of SEBI (SCAT) Regulations 2011.
Counsel—
SectorBFSI
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Archives – Bandhan Bank SCAT Disclosure · official
- SEBI (SCAT) Regulations, 2011 – Official Text · official
- RBI – Guidelines on Fit and Proper Criteria for Bank Shareholding · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- S&R Associates, Trilegal act on Gaja Capital ₹550 crore IPO31 Aug 2026 · ₹550 cr
- Arman Financial Services Limited: Disclosure under SEBI Takeover Regulations31 Aug 2026
- Time Technoplast Board Approves ₹50 Cr Equity Investment in Time Intercontinental26 Aug 2026 · ₹50 cr
- Honasa Consumer proposes acquisition of Fluence Pharma25 Aug 2026
- NCLT Mumbai approves selective reduction of equity capital in Godrej Redevelopers (Mumbai) subsidiary25 Aug 2026
- HEG Demerger to Take Effect from September 1, 2026; Record Date Fixed for September 7, 202625 Aug 2026